Global Autoimmune Disease Diagnostics Market Size, Share and COVID-19 Impact Analysis By Type (Systemic Autoimmune Disease [Rheumatoid Arthritis, Psoriasis, Systemic Lupus Erythematosus (SLE), Multiple Sclerosis, Other Systemic Autoimmune Diseases and Localized Autoimmune Disease Inflammatory Bowel Disease, Type 1 Diabetes, Thyroid, and Other Localized Autoimmune Diseases]), By Diagnosis Type (Antinuclear Antibody Tests, Autoantibody Tests, Complete Blood Count (CBC), C-reactive Protein (CRP), Urinalysis and Others tests), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2021 – 2030.
Premium Report Details
Base Year:
2021
Tables & Figures:
108
Pages:
190
Countries covered:
16
Companies covered::
20
Forecast CAGR:
9%
Connect with us
smartphone
smartphone
email
email
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we
also
use cookies to show you personalized ads? Learn
more and manage your cookies